UK – Guidance : Managing clinical trials during Coronavirus (COVID-19)

How investigators and sponsors should manage clinical trials during COVID-19

This guidance has been developed to assist those involved in clinical trials disrupted as a result of COVID-19. It is relevant to those involved with ongoing studies, those wishing to restart trials that have been paused or temporarily halted, and those wishing to start new studies…